Using genomics to define the antigenic targets of checkpoint blockade cancer immunotherapy

被引:0
作者
Schreiber, Robert D.
机构
关键词
D O I
10.1158/2326-6074.TUMIMM14-IA08
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IA08
引用
收藏
页数:2
相关论文
共 50 条
[31]   Mechanisms underlying response and resistance to immune checkpoint blockade in cancer immunotherapy [J].
Lee, Junghwa ;
Kim, Eui Ho .
FRONTIERS IN ONCOLOGY, 2023, 13
[32]   Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade [J].
Emens, Leisha A. .
EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (12) :1597-1611
[33]   Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors [J].
Roy, Dia ;
Gilmour, Cassandra ;
Patnaik, Sachin ;
Wang, Li Lily .
FRONTIERS IN IMMUNOLOGY, 2023, 14
[34]   Neoadjuvant immune checkpoint blockade: A window of opportunity to advance cancer immunotherapy [J].
Topalian, Suzanne L. ;
Forde, Patrick M. ;
Emens, Leisha A. ;
Yarchoan, Mark ;
Smith, Kellie N. ;
Pardoll, Drew M. .
CANCER CELL, 2023, 41 (09) :1551-1566
[35]   A Pan-Cancer Immunogenomic Atlas for Immune Checkpoint Blockade Immunotherapy [J].
Yang, Jing ;
Zhao, Shilin ;
Wang, Jing ;
Sheng, Quanhu ;
Liu, Qi ;
Shyr, Yu .
CANCER RESEARCH, 2022, 82 (04) :539-542
[36]   Immunotherapy in breast cancer: An overview of modern checkpoint blockade strategies and vaccines [J].
Sanchez, Katherine ;
Page, David ;
McArthur, Heather L. .
CURRENT PROBLEMS IN CANCER, 2016, 40 (2-4) :151-162
[37]   A reappraisal of CTLA-4 checkpoint blockade hypothesis in cancer immunotherapy [J].
Du, Xuexiang ;
Tang, Fei ;
Liu, Mingyue ;
Zheng, Pan ;
Liu, Yang .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 81 :59-59
[38]   Hypoxia-responsive immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy for potentiating cancer immunotherapy [J].
Chen, Weiguo ;
Sheng, Ping ;
Chen, Yujiang ;
Liang, Yi ;
Wu, Sixin ;
Jia, Liying ;
He, Xin ;
Zhang, Chunfeng ;
Wang, Chongzhi ;
Yuan, Chunsu .
Chemical Engineering Journal, 2022, 451
[39]   Hypoxia-responsive immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy for potentiating cancer immunotherapy [J].
Chen, Weiguo ;
Sheng, Ping ;
Chen, Yujiang ;
Liang, Yi ;
Wu, Sixin ;
Jia, Liying ;
He, Xin ;
Zhang, Chunfeng ;
Wang, Chongzhi ;
Yuan, Chunsu .
CHEMICAL ENGINEERING JOURNAL, 2023, 451
[40]   Immunogenomics: using genomics to personalize cancer immunotherapy [J].
Siniard, Rance C. ;
Harada, Shuko .
VIRCHOWS ARCHIV, 2017, 471 (02) :209-219